FRI-183-A phase 3 study comparing switching from tenofovir disoproxil fumarate to tenofovir alafenamide with continued TDF treatment in virologically-suppressed patients with chronic hepatitis B (CHB): week 48 efficacy and safety results

Journal article

Peer reviewed

Pietro Lampertico, Maria Buti, Scott Fung, Sang Hoon Ahn, Wan-Long Chuang, Alnoor Ramji, Won Young Tak, Chiyi Chen, Edward Tam, Ho Bae, …

Journal of hepatology, v 70(1), pp e470-e471

Apr 2019

Additional Links

10 Record Views

Title: FRI-183-A phase 3 study comparing switching from tenofovir disoproxil fumarate to tenofovir alafenamide with continued TDF treatment in virologically-suppressed patients with chronic hepatitis B (CHB): week 48 efficacy and safety results
Creators: Pietro Lampertico
Maria Buti
Scott Fung
Sang Hoon Ahn
Wan-Long Chuang
Alnoor Ramji
Won Young Tak
Chiyi Chen
Edward Tam
Ho Bae
Xiaoli Ma
John F. Flaherty
Anuj Gaggar
Audrey Lau
Becket Feierbach
George Wu
Vithika Suri
Mani Subramanian
Huy N. Trinh
Seung Kew Yoon
Kosh Agarwal
Young-Suk Lim
Henry Chan
Publication Details: Journal of hepatology, v 70(1), pp e470-e471
Publisher: Elsevier
Resource Type: Journal article
Language: English
Academic Unit: Medicine (Graduate)
Web of Science ID: WOS:000463481702016
Other Identifier: 991019167519304721

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types: Industry collaboration; Domestic collaboration; International collaboration
Web of Science research areas: Gastroenterology & Hepatology